Bristol Myers Squibb secures FDA nod for Breyanzi in marginal zone lymphoma
The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
Siponimod Tablets is indicated for the treatment of relapsing forms of multiple sclerosis
AEF0217 is a first-in-class CB1 receptor signaling-specific inhibitor
Grant of Permission to manufacture and market FDC of Naproxen Delayed Release and Esomeprazole capsule (375mg/500mg + 20mg/20mg)
Jaypirca is the first and only FDA-approved non-covalent (reversible) BTK inhibitor
The PCR-based test, delivered via Roche’s cobas liat system, allows results to be obtained during a patient consultation in GP practices and Emergency Rooms
Here's a development that aims to keep your blood pressure in check. Literally!
The company is excluding data from the affected sites to maintain the study's integrity
Suffering from acute migraine? You may soon bid adieu to the debilitating headache
Presbyopia, the age-related loss of near vision, could soon be treated successfully
Subscribe To Our Newsletter & Stay Updated